BioProcess International
 
 

Downstream Case Study


 

Mycoplasma In-Process and Lot Release Testing: To PCR or Not to PCR

Yuan Xu, William Egan, Andrew Chang, and Keith Webber

BioProcess International, December 2005

 

Mycoplasma are the simplest self-replicating prokaryotes, and they are frequent contaminants of cell cultures. Mycoplasma infection can affect nearly every cell culture parameter and result in decreased quantity or quality of product, inconsistency of manufacture, or possible adverse effects in recipients. Because of this, detection of mycoplasma is extremely important; but because of their small size, limited turbidity produced in culture, the wide diversity of mycoplasma species, and other factors, detection of mycoplasma can be challenging.

 

Some common culture methods of mycoplasma detection for cell bank and raw material release, in-process, and lot release testing have a long turnaround time (minimum 28 days). For most biological products, the mycoplasma culture test is the rate-limiting step for lot release. This white paper examines alternate methods of mycoplasma detection with shorter turnaround times, such as polymerase-chain-reaction (PCR)—based assays.

 

Download PDF

 

 

Targeted BPI Content

 

A Brief History of Perfusion Biomanufacturing
BioProcess International, October 2011
Read more. 

 

Microanalytical Techniques for Identifying Nonprotein Contaminants in Biologics
BioProcess International, February 2010
Read more.

 

Performance Characteristics of Host-pCell DNA Quantification Methods
BioProcess International, October 2007
Read more.

 

How to Choose an Industrial Cation Exchanger for IgG Purification
BioProcess International, October 2010
Read more.

 

Scale-Up of a Plasmid DNA Purification Process
BioProcess International, December 2010
Read more. 

 

Biopharmaceutical Quality Assurance
BioProcess International, November 2008
Read more. 

 

 

Powered by Powered by PropelMG  
 
 
Visit BioProcess International Home